Received Nov 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 42Y93 | — |
inadvertent administration of Kinrix to a 2-month-old patient; Kinrix the first DTaP-IPV immunization for this patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old female patient who received DTPa-IPV (Kinrix) (batch number 42Y93, expiry date 05-JUN-2026) for prophylaxis. On 09-SEP-2025, the patient received Kinrix. On 09-SEP-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: inadvertent administration of Kinrix to a 2-month-old patient) and inappropriate schedule of vaccine administered (Verbatim: Kinrix the first DTaP-IPV immunization for this patient). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 14-NOV-2025 The registered nurse wanted to get a recommendation on the inadvertent administration of Kinrix to a 2-month-old patient (when DTaP-IPV was supposed to be given, being the Kinrix the first DTaP-IPV immunization for this patient). The Vaccine Administration Facility was the same as primary reporter.